Sarrouilhe D, Métayé T, Rivet G, Lalégerie P, Baudry M
Groupe de Recherche et d'Etude d' Analogues de Médicaments, Faculté de Médecine et de Pharmacie, Poitiers, France.
Cell Mol Biol (Noisy-le-grand). 1993 Jul;39(5):469-77.
Rat liver plasma membrane alkaline phosphatase (ALP) phospho-intermediates, which have molecular masses of 151 and 135 kDa bands, were labelled at physiological pH with either (gamma-32P) ATP or 32Pi. This labeling was stabilized by a potent enzyme inhibitor, bromolevamisole (BL), and not by bromodexamisole (BD). BL augmented the rate and extent of autophosphorylation and slowed down the rate of autodephosphorylation of ALP. The phospho-intermediates labeling presented nearly the same kinetic behaviour with either (gamma-32P) ATP or 32Pi. In the presence of BL a marked decrease of the phosphorylation state of many proteins was observed in hepatocytes. BL also produced a decrease of the 32Pi uptake into hepatocytes and a decrease of the specific radioactivity of cellular ATP. BD had nearly the same effect as BL on protein phosphorylation and 32Pi uptake. These results argued against a direct involvement of ALP in Pi transport across hepatocyte plasma membrane.
大鼠肝细胞膜碱性磷酸酶(ALP)的磷酸化中间体,其分子量分别为151 kDa和135 kDa条带,在生理pH值下用(γ-32P)ATP或32Pi进行标记。这种标记通过一种有效的酶抑制剂溴左旋咪唑(BL)得以稳定,而溴地塞米松(BD)则不能。BL增强了ALP的自磷酸化速率和程度,并减缓了其自去磷酸化速率。磷酸化中间体的标记无论是用(γ-32P)ATP还是32Pi,都呈现出几乎相同的动力学行为。在BL存在的情况下,肝细胞中许多蛋白质的磷酸化状态显著降低。BL还导致肝细胞对32Pi的摄取减少以及细胞ATP比放射性降低。BD对蛋白质磷酸化和32Pi摄取的影响与BL几乎相同。这些结果表明ALP并非直接参与Pi跨肝细胞膜的转运。